CASEY STELTER: Open Payments
NPI 1073607222 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 13 payments from 9 companies in 2025. Trend: 2023 $446 · 2024 $408 · 2025 $340
Food & beverage: $260Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $87 |
| Astellas Pharma US Inc | 1 | $80 |
| Amgen Inc. | 2 | $51 |
| Boston Scientific Corporation | 1 | $24 |
| Abbott Laboratories | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Cranial Technologies, Inc | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: VRAYLAR, EVENITY, UBRELVY, WATCHMAN Access System, FREESTYLE LIBRE 3, NURTEC ODT, LEQVIO, Doc Band.
Industry payments across UT — which companies pay providers there.
